GroupPrimary regimenAlternative regimenConsiderations
ASingle dose of ceftriaxone (Rocephin), 250 mg intramuscularly, or single dose of cefixime (Suprax), 400 mg orallyRegimen covers Neisseria gonorrhoeae and Chlamydia trachomatis infections in addition to other common bacterial pathogens
then
Doxycycline, 100 mg orally twice daily for 10 days
BCiprofloxacin, 500 mg orally twice daily for 10 to 14 daysTrimethoprim/sulfamethoxazole, 160/800 mg orally twice daily for 10 to 14 daysExtend treatment for 2 weeks if patient remains symptomatic
or
Levofloxacin (Levaquin), 500 to 750 mg orally daily for 10 to 14 days
CCiprofloxacin, 400 mg IV every 12 hoursCeftriaxone, 1 to 2 g IV every 24 hoursContinue treatment until patient is afebrile, then transition to oral regimen (group B) for an additional 2 to 4 weeks
orplus
Levofloxacin, 500 to 750 mg IV every 24 hoursLevofloxacin, 500 to 750 mg IV every 24 hours
or
Piperacillin/tazobactam (Zosyn), 3.375 g IV every 6 hours
DPiperacillin/tazobactam, 3.375 g IV every 6 hours plus aminoglycosides*Fluoroquinolone (group C)Continue treatment until patient is afebrile, then transition to oral regimen (group B) for an additional 2 to 4 weeks
plus
orAminoglycosides*
Cefotaxime (Claforan), 2 g IV every 4 hours plus aminoglycosides*or
orErtapenem (Invanz), 1 g IV every 24 hours
Ceftazidime (Fortaz), 2 g IV every 8 hours plus aminoglycosides*or
Imipenem/cilastatin (Primaxin), 500 mg IV every 6 hours
or
Meropenem (Merrem IV), 500 mg IV every 8 hours
ETransrectal manipulation—fluoroquinolone resistance and extended spectrum beta-lactamase–producing Escherichia coliContinue treatment until patient is afebrile, then transition to oral regimen (group B) for an additional 2 to 4 weeks
Carbapenems can be used if patient is unstable
Piperacillin/tazobactam, 3.375 g IV every 6 hours plus aminoglycosides*Ertapenem, 1 g IV every 24 hoursIf patient is stable, follow primary regimen while awaiting culture results
or
Imipenem/cilastatin, 500 mg IV every 6 hours
Transurethral manipulation—Pseudomonas species
Piperacillin/tazobactam, 3.375 g IV every 6 hoursFluoroquinolone (group C)
oror
Ceftazidime, 2 g IV every 8 hoursImipenem/cilastatin, 500 mg IV every 6 hours
oror
Cefipime, 2 g IV every 12 hoursMeropenem, 500 mg IV every 8 hours
Fluoroquinolone exposure—fluoroquinolone resistance
Piperacillin/tazobactam, 3.375 g IV every 6 hoursCeftriaxone, 1 g IV every 24 hours
oror
Ceftazidime, 2 g IV every 8 hoursErtapenem, 1 g IV every 24 hours
or
Cefepime, 2 g IV every 12 hours